Scientists at UC San Francisco have developed a revolutionary cancer treatment that precisely targets tumors with radiation ...
Our results offer 'proof of concept' for the future use of a pharmaceutical senolytic strategy to reduce the risk of ...
Cancer therapy has always struggled with targeting tumor cells effectively while minimizing damage to healthy tissue.
Among patients in the real world with unresectable or metastatic urothelial carcinoma, Padcev significantly improved overall ...
Saskatchewan cervical cancer patients now have access to a specialized radiation therapy treatment previously only available ...
John Ryan, a U.S. Navy veteran, beat cancer through nearly a decade of experimental immunotherapy treatment. The vet shared ...
A new research paper was published by Aging (Aging-US) on January 8, 2025, in Volume 17, Issue 1, titled "Senolytic agent ABT-263 mitigates low- and high-LET radiation-induced gastrointestinal cancer ...
All the snow last week and the cold air this week is making for some dangerous temperatures.But how can snow, make the cold worse.Firstly, those two factors pro ...
Guam Regional Medical City announced the addition of Dr. Kin-Sing Au, a board-certified radiation oncologist with more than ...
A discovery of how to target mutated proteins in tumors made a decade ago never matured into a surefire way of destroying ...
A new cervical cancer treatment is showing promise in boosting survival rates and reducing recurrence What this breakthrough means for patients.
PSA doubling time is an essential criterion for high-risk biochemically recurrent prostate cancer that should prompt treatment escalation.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results